Increased apolipoprotein e level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 59, Issue 10, 2010, Pages 1502-1509

  Söderlund, Sanni ^a   Watanabe, Hiroshi ^a   Ehnholm, Christian ^b   Jauhiainen, Matti ^b   Taskinen, Marja Riitta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; AGED; BLOOD; MIDDLE AGED; MOLECULAR WEIGHT; RISK FACTOR; SEX DIFFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS E; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOLECULAR WEIGHT; PARTICLE SIZE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 77956974113     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.01.015     Document Type: Article

References (38)

1. Gordon T., Castelli W.P., and Hjortland M.C. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med 62 1977 707 714
2. Barter P., Gotto A.M., and LaRosa J.C. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events N Engl J Med 357 2007 1301 1310
3. von Eckardstein A., Nofer J.R., and Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport Arterioscler Thromb Vasc Biol 21 2001 13 27
4. Cohn J.S., Tremblay M., and Amiot M. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects Arterioscler Thromb Vasc Biol 16 1996 149 159
5. Heeren J., Beisiegel U., and Grewal T. Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis Arterioscler Thromb Vasc Biol 26 2006 442 448
6. Aromaa A., and Koskinen S. Health and functional capacity in Finland: baseline results of the Health 2000 Health Examination Survey 2004 National Public Health Institute Helsinki, Finland
7. (ADA) ADA Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
8. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition Lancet 366 2005 1059 1062
9. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
10. Siggins S., Jauhiainen M., and Olkkonen V.M. PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma J Lipid Res 44 2003 1698 1704
11. Havekes L.M., de Knijff P., and Beisiegel U. A rapid micromethod for apolipoprotein E phenotyping directly in serum J Lipid Res 28 1987 455 463
12. Blanche P.J., Gong E.L., and Forte T.M. Characterization of human high-density lipoproteins by gradient gel electrophoresis Biochim Biophys Acta 665 1981 408 419
13. Nakanishi S., Vikstedt R., and Soderlund S. Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity J Lipid Res 50 2008 183 192
14. Perusse M., Pascot A., and Despres J.P. A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma J Lipid Res 42 2001 1331 1334
15. Vakkilainen J., Jauhiainen M., and Ylitalo K. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins J Lipid Res 43 2002 598 603
16. Damen J., Regts J., and Scherphof G. Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay Biochim Biophys Acta 712 1982 444 452
17. Jauhiainen M., and Ehnholm C. Determination of human plasma phospholipid transfer protein mass and activity Methods 36 2005 97 101
18. Siggins S., Karkkainen M., and Tenhunen J. Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA J Lipid Res 45 2004 387 395
19. Groener J.E., Pelton R.W., and Kostner G.M. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma Clin Chem 32 1986 283 286
20. Linton M.F., Atkinson J.B., and Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation Science 267 1995 1034 1037
21. Kypreos K.E., and Zannis V.I. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT Biochem J 403 2007 359 367
22. Yu H., Zhang W., and Yancey P.G. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice Arterioscler Thromb Vasc Biol 26 2006 150 156
23. Olivieri O., Martinelli N., and Bassi A. ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome Clin Exp Med 7 2007 164 172
24. Dergunov A.D., Visvikis-Siest S., and Siest G. Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis Vascul Pharmacol 48 2008 70 75
25. Krimbou L., Marcil M., and Chiba H. Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles J Lipid Res 44 2003 884 892
26. Wilson H.M., Patel J.C., and Russell D. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease Clin Chim Acta 220 1993 175 187
27. Matsuura F., Wang N., and Chen W. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway J Clin Invest 116 2006 1435 1442
28. Vaisar T., Pennathur S., and Green P.S. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL J Clin Invest 117 2007 746 756
29. Green P.S., Vaisar T., and Pennathur S. Combined statin and niacin therapy remodels the high-density lipoprotein proteome Circulation 118 2008 1259 1267
30. Janis M.T., Metso J., and Lankinen H. Apolipoprotein E activates the low-activity form of human phospholipid transfer protein Biochem Biophys Res Commun 331 2005 333 340
31. Cheung M.C., Wolfbauer G., and Deguchi H. Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology Biochim Biophys Acta 1791 2009 206 211
32. Dullaart R.P., Groen A.K., and Dallinga-Thie G.M. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol Eur J Endocrinol 158 2008 53 60
33. Pascot A., Lemieux I., and Prud'homme D. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity J Lipid Res 42 2001 2007 2014
34. Watanabe H., Soderlund S., and Soro-Paavonen A. Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness Arterioscler Thromb Vasc Biol 26 2006 897 902
35. Asztalos B.F., Lefevre M., and Foster T.A. Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations Arterioscler Thromb Vasc Biol 17 1997 1885 1893
36. Yang Y., Yan B., and Fu M. Relationship between plasma lipid concentrations and HDL subclasses Clin Chim Acta 354 2005 49 58
37. Haddy N., De Bacquer D., and Chemaly M.M. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe Eur J Hum Genet 10 2002 841 850
38. Moreno J.A., Perez-Jimenez F., and Moreno-Luna R. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects Br J Nutr 101 2009 1745 1752